Tissue-Specific Mutations in BRAF and EGFR Necessitate Unique Therapeutic Approaches

Trends in Cancer - United States
doi 10.1016/j.trecan.2016.10.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2

Cancer Cell
Cancer ResearchOncologyCell Biology
2016English

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2015English

Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas With Specific CDKN2A Germline Alterations

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2010English

BRAF Mutations in Acute Leukemias

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

BRAF; Epidermal Growth Factor Receptor (EGFR)

Science-Business eXchange
2012English

Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2015English

Concomitant KIT/BRAF and PDGFRA/BRAF Mutations Are Rare Events in Gastrointestinal Stromal Tumors

Oncotarget
Oncology
2016English

Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances Between Immunohistochemistry and Sequencing

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

PCR-based Detection of EGFR, ALK, KRAS and BRAF Mutations in Russian Patients With Lung Adenocarcinoma: A Single-Center Experience

Neoplasma
Cancer Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy